Takeda’s Next-Gen Therapy TAK-881 Meets Key Milestone: A Potential Shift in Primary Immunodeficiency Care
CAMBRIDGE, Mass. — Takeda Pharmaceutical announced on May 4, 2026, that its investigational drug TAK-881 successfully met the primary endpoint in a...
“Is It Just a Summer Fever?” ICMR’s Syndromic Surveillance Aims to Catch India’s Next Outbreak Before It Spreads
May 5, 2026 As sweltering seasonal heat and unpredictable weather patterns fuel a rise in acute fevers across India, the Indian Council of Medical...
Vigilance in Saluda County: South Carolina Confirms Second Measles Case Amid Nationwide Surge
SALUDA COUNTY, SC — The South Carolina Department of Public Health (DPH) confirmed a second case of measles in Saluda County on May 4, 2026. This...
The Digital Divide of Distress: How Social Media Hits Disadvantaged Teens Hardest
Published: May 5, 2026 A massive global analysis of more than 330,000 adolescents across 43 countries has identified a disturbing trend in the...
The “Ozempic Effect”: How Rapid Weight Loss is Reshaping the Aesthetics Industry
Published: May 5, 2026 As the global healthcare landscape navigates the mid-2026 milestone, the ripple effects of GLP-1 receptor agonist...
